Fard-Esfahani, A., Emami-Ardekani, A., Fallahi, B., Fard-Esfahani, P., Beiki, D., Hassanzadeh-Rad, A., & Eftekhari, M. (2014). Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nuclear Medicine Communications, 35(8), 808–817. https://doi.org/10.1097/MNM.0000000000000132
Article CAS PubMed Google Scholar
Duan, H., Gamper, E., Becherer, A., & Hoffmann, M. (2015). Quality of life aspects in the management of thyroid cancer. Oral Oncology, 51(6), S1-5. https://doi.org/10.1016/j.oraloncology.2015.03.008
Article CAS PubMed Google Scholar
Institute of Medicine & National Research Council. (2006). From Cancer Patient to Cancer Survivor: Lost in Transition. The National Academies Press. https://doi.org/10.17226/11468
Levit, L. A., Balogh, E., Nass, S. J., & Ganz, P. (2013). Delivering high-quality cancer care: Charting a new course for a system in crisis. National Academies Press Washington.
Caglar, M., Tuncel, M., & Alpar, R. (2002). Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clinical Nuclear Medicine, 27(11), 767–771.
Esfahani, A. F., Fallahi, B., Olamaie, R., Eftekhari, M., Beiki, D., & Saghari, M. (2004). Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment. Hellenic Journal of Nuclear Medicine, 7(3), 206–209.
Nakada, K., Ishibashi, T., Takei, T., Hirata, K., Shinohara, K., Katoh, S., Zhao, S., Tamaki, N., Noguchi, Y., & Noguchi, S. (2005). Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? Journal of Nuclear Medicine, 46(2), 261–266.
Solans, R., Bosch, J.-A., Galofré, P., Porta, F., Roselló, J., Selva-O’Callagan, A., & Vilardell, M. (2001). Salivary and lacrimal gland dysfunction (Sicca Syndrome) after radioiodine therapy. Journal of Nuclear Medicine, 42(5), 738–743.
Thomson, W. M., Chalmers, J. M., Spencer, A. J., & Williams, S. M. (1999). The Xerostomia Inventory: A multi-item approach to measuring dry mouth. Community Dental Health, 16(1), 12–17.
Bian, X., Song, T., & Wu, S. (2015). Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: Based on the EORTC QLQ-C30 and H&N35 questionnaires. Expert Review of Anticancer Therapy, 15(1), 109–119. https://doi.org/10.1586/14737140.2015.961427
Article CAS PubMed Google Scholar
Eisbruch, A., Kim, H. M., Terrell, J. E., Marsh, L. H., Dawson, L. A., & Ship, J. A. (2001). Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 50(3), 695–704. https://doi.org/10.1016/S0360-3016(01)01512-7
Article CAS PubMed Google Scholar
Bowman, S. J., Booth, D. A., Platts, R. G., Field, A., Rostron, J., UK Sjögren’s Interest Group. (2003). Validation of the Sicca symptoms inventory for clinical studies of Sjögren’s syndrome. The Journal of Rheumatology, 30(6), 1259–1266.
Sherman, A. C., Simonton, S., Adams, D. C., Vural, E., Owens, B., & Hanna, E. (2000). Assessing quality of life in patients with head and neck cancer: Cross-validation of the European organization for research and treatment of cancer (EORTC) quality of life head and neck module (QLQ-H&N35). Archives of Otolaryngology-Head & Neck Surgery, 126(4), 459–467. https://doi.org/10.1001/archotol.126.4.459
Bjordal, K., Hammerlid, E., Ahlner-Elmqvist, M., de Graeff, A., Boysen, M., Evensen, J., Biörklund, A., Leeuw, R., Fayers, P., Jannert, M., Westin, T., & Kaasa, S. (1999). Quality of life in head and neck cancer patients: Validation of the european organization for research and treatment of cancer quality of life questionnaire-H&N35. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 17, 1008–1019. https://doi.org/10.1200/JCO.1999.17.3.1008
Article CAS PubMed Google Scholar
Verdonck-de Leeuw, I. M., Buffart, L. M., Heymans, M. W., Rietveld, D. H., Doornaert, P., de Bree, R., Buter, J., Aaronson, N. K., Slotman, B. J., Leemans, C. R., & Langendijk, J. A. (2014). The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: A prospective cohort study. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 110(3), 422–428. https://doi.org/10.1016/j.radonc.2014.01.002
Seror, R., Theander, E., Bootsma, H., Bowman, S. J., Tzioufas, A., Gottenberg, J.-E., Ramos-Casals, M., Dörner, T., Ravaud, P., Mariette, X., & Vitali, C. (2014). Outcome measures for primary Sjögren’s syndrome: A comprehensive review. Journal of Autoimmunity, 51, 51–56. https://doi.org/10.1016/j.jaut.2013.12.010
Thomson, W. M. (2007). Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Gerodontology, 24(1), 30–35. https://doi.org/10.1111/j.1741-2358.2007.00137.x
Gulati, A., Kidane, J., & Chang, J. L. (2023). Patient reported outcome measures for salivary function: A systematic review. The Laryngoscope. https://doi.org/10.1002/lary.30550
Bhayani, M. K., Acharya, V., Kongkiatkamon, S., Farah, S., Roberts, D. B., Sterba, J., Chambers, M. S., & Lai, S. Y. (2015). Sialendoscopy for patients with radioiodine-induced sialadenitis and xerostomia. Thyroid, 25(7), 834–838.
Article CAS PubMed PubMed Central Google Scholar
La Perle, K. M., Kim, D. C., Hall, N. C., Bobbey, A., Shen, D. H., Nagy, R. S., Wakely, P. E., Jr., Lehman, A., Jarjoura, D., & Jhiang, S. M. (2013). Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid, 23(8), 1029–1036.
Article PubMed PubMed Central Google Scholar
Gning, I., Trask, P. C., Mendoza, T. R., Harle, M. T., Gutierrez, K. A., Kitaka, S. A., Sherman, S. I., & Cleeland, C. S. (2009). Development and initial validation of the thyroid cancer module of the MD anderson symptom inventory. Oncology, 76(1), 59–68.
Husson, O., Haak, H. R., Buffart, L. M., Nieuwlaat, W.-A., Oranje, W. A., Mols, F., Kuijpens, J. L., Coebergh, J. W., & van de Poll-Franse, L. V. (2013). Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: A study from the population-based PROFILES registry. Acta Oncologica, 52(2), 249–258.
Husson, O., Haak, H. R., Mols, F., Nieuwenhuijzen, G. A., Nieuwlaat, W.-A., Reemst, P. H., Huysmans, D. A., Toorians, A. W., & van de Poll-Franse, L. V. (2013). Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncologica, 52(2), 447–454. https://doi.org/10.3109/0284186X.2012.718445
Buchholzer, S., Thakachy Subha, S., Tchérémissinoff, L., Boselie, F., Triponez, F., Faure, F., Lopez, J.-M., Borner, U., Kleinjung, T., Seebach, J. D., Dulguerov, P., & Marchal, F. (2021). The RAI-6 questionnaire: A new screening questionnaire to monitor complications of radioiodine treatment. Frontiers in Surgery. https://doi.org/10.3389/fsurg.2021.641945
Article PubMed PubMed Central Google Scholar
Le Roux, M., Graillon, N., Guyot, L., Taieb, D., Galli, P., Godio-Raboutet, Y., Chossegros, C., & Foletti, J. (2020). Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study. Head & Neck, 42(11), 3133–3140.
Kim, Y., Choi, J., Hong, S. B., Hyun, I. Y., & Lim, J. (2016). Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis. Head & Neck, 38(1), 51–58.
Moreddu, E., Baumstarck-Barrau, K., Gabriel, S., Fakhry, N., Sebag, F., Mundler, O., Chossegros, C., & Taïeb, D. (2017). Incidence of salivary side effects after radioiodine treatment using a new specifically-designed questionnaire. British Journal of Oral and Maxillofacial Surgery, 55(6), 609–612. https://doi.org/10.1016/j.bjoms.2017.03.019
Article CAS PubMed Google Scholar
Baudin, C., Bressand, A., Buffet, C., Menegaux, F., Soret, M., Lê, A. T., Cardon, T., Broggio, D., Bassinet, C., Huet, C., Armengol, G., Richardson, D. B., Leenhardt, L., Bernier, M.-O., & Lussey-Lepoutre, C. (2023). Dysfunction of the salivary and lacrimal glands after radioiodine therapy for thyroid cancer: Results of the START study after 6-months of follow-up. Thyroid. https://doi.org/10.1089/thy.2023.0090
Singer, S., Al-Ibraheem, A., Pinto, M., Iakovou, I., Østhus, A. A., Hammerlid, E., Locati, L. D., Gamper, E., Ignacio, J., Jordan, S. J., Kiyota, N., Buettner, M., Engesser, D., Canotilho, R., Ioannidis, G., Husson, O., Gama, R. R., Fanetti, G., Moss, L., … Sykiotis, G. (2023). International phase IV field study for the reliability and validity of the european organisation for research and treatment of cancer thyroid cancer module EORTC QLQ-THY34. Thyroid: Official Journal of the American Thyroid Association, 33(9), 1078–1089. https://doi.org/10.1089/thy.2023.0221
Diamond-Rossi, S. A., Jonklaas, J., Jensen, R. E., Kuo, C., Stearns, S., Esposito, G., Davidson, B. J., Luta, G., Bloom, G., & Graves, K. D. (2020). Looking under the hood of “the Cadillac of cancers:” radioactive iodine-related craniofacial side effects among patients with thyroid cancer. Journal of Cancer Survivorship: Research and Practice, 14(6), 847–857. https://doi.org/10.1007/s11764-020-00897-5
Willis, G., Lawrence, D., Thompson, F., Kudela, M., Levin, K., & Miller, K. (2005). The use of cognitive interviewing to evaluate translated survey questions: Lessons learned. Conference of the Federal Committee on Statistical Methodology, Arlington, VA.
Lenzner, T., Hadler, P., & Neuert, C. (2023). An experimental test of the effectiveness of cognitive interviewing in pretesting questionnaires. Quality & Quantity, 57(4), 3199–3217. https://doi.org/10.1007/s11135-022-01489-4
Klein Hesselink, E. N., Brouwers, A. H., de Jong, J. R., van der Horst-Schrivers, A. N. A., Coppes, R. P., Lefrandt, J. D., Jager, P. L., Vissink, A., & Links, T. P. (2016). Effects of radioiodine treatment on salivary gland function in patients with differentiated thyroid carcinoma: A prospective study. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 57(11), 1685–1691. https://doi.org/10.2967/jnumed.115.169888
Article CAS PubMed Google Scholar
Thomson, W. M., & Williams, S. M. (2000). Further testing of the xerostomia inventory. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 89(1), 46–50. https://doi.org/10.1016/s1079-2104(00)80013-x
Article CAS PubMed Google Scholar
Peterman, A. H., Fitchett, G., Brady, M. J., Hernandez, L., & Cella, D. (2002). Measuring spiritual well-being in people with cancer: The functional assessment of chronic illness therapy–Spiritual Well-being Scale (FACIT-Sp). Annals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine, 24(1), 49–58. https://doi.org/10.1207/S15324796ABM2401_06
留言 (0)